These data led us to speculate that CD9-positive cells may differentiate into endothelial cells via the up-regulation of Id2 expression in the early stage of DES-treatment, as capillaries were extended and tortuous and haemorrhages were often present in tumour tissues at 12 weeks. The gene discussed is CD9; the disease is neoplasm.